BioSpace News Archive

Align Technology, Inc. introduced a new doctor enabled direct ship to patient feature in its Vivera™ Retainer Subscription platform that allows doctors to have subsequent retainers sent directly to their patients in order to meet their ongoing long-term retention needs.

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced it has received Abbreviated New Drug Application (“ANDA”) approval from the U.S. Food and Drug Administration (“FDA”) for calcium gluconate in sodium chloride injection, 1000 mg/50 mL and 2000 mg/100 mL.

Centene Corporation, a leading healthcare enterprise committed to helping people live healthier lives, announced that it has been named to Fortune’s “Best Workplaces in Health Care” list for a second year in a row.

Natera, Inc., a global leader in cell-free DNA testing, announced the launch of a proposed follow-on public offering of $250,000,000 of shares of its common stock.

Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 21st Annual Global Healthcare Conference on Tuesday, Sept. 12, 2023.

Aditxt, Inc. announced that it has closed its previously announced private placement for the purchase and sale of an aggregate of 1,000,000 shares of common stock at a purchase price of $10.00 per share and accompanying warrant, priced at-the-market under Nasdaq rules.

Moderna, Inc. (Nasdaq:MRNA), today announced its participation in a fireside chat at Morgan Stanley’s 21st Annual Global Healthcare Conference on Tuesday, September 12th at 12:15 p.m. ET.

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that it has disclosed certain historical and pro forma financial information with respect to its proposed acquisition of XIIDRA (lifitegrast ophthalmic solution) 5% and certain other ophthalmology assets (“Acquisition”) on a Current Report on Form 8-K and on its SEDAR+ (www.sedarplus.ca) profile.

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announced that its management team will participate in the following upcoming investor conferences.

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will participate in a fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference on Wednesday, September 13 at 12:00 p.m. ET.